Latest Breaking News On - Rosen high way - Page 1 : comparemela.com

IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K -December 07, 2023 at 07:11 am EST

MONTHLY PROGRESS REPORT Name of Listed Issuer: IM Cannabis Corp. Trading Symbol: IMCC Number of Outstanding Listed.

British columbiaState of israelAdjupharm gmbhOren shusterMichal lebovitz nissimovMichael wienerMinistry of healthOntario superior courtOak holdings ltdMw investments ltdNational instrumentHerbs ltdHoldings ltdRosen high way ltdExchange requirementsIm cannabis corp

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

/PRNewswire/ IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany.

Adjupharm gmbOren shusterAnna tarankoTrichome financial corpCanadian securities exchangeHerbs ltdSource im cannabis corpIm cannabis corpRosen high way ltdIsraeli defenseCompany contactsCompany the participating insiderHoldings ltdChief executive officerIsrael hamas warRosen high way

IM Cannabis Corp : IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

IM Cannabis Corp : IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Oren shusterAnna tarankoAdjupharm gmbRosen high way ltdPrnewswire im cannabis corpCanadian securities exchangeHerbs ltdCompany the participating insiderIsraeli defenseCompany contactsHoldings ltdIm cannabis corpTrichome financial corpChief executive officerIsrael hamas warRosen high way

IM Cannabis Q1 Revenue Increases 18% Sequentially to $23 6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million. Gross Profit Increased 37% from Q1 2021 as Operational. #imcannabis #IMCHoldings #imcc

Israel generalUnited statesVironna pharmOren shusterSde avrahamAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdIsraeli medical cannabis agencyCompany expects to achieve positive adjustedPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corp

IM Cannabis Q4 Revenue Increases 35% Sequentially to C$20 Million

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook. Fiscal Year 2021 revenues increased 242%. #imcannabis #imc #imcc

Israel generalUnited statesOranim pharmOren shusterAdjupharm gmbhPharm yarokHerbs ltdRosen high way ltdOntario cannabisIsraeli medical cannabis agencyPanaxia labs israel ltdNutraceuticals incInternational financial reporting standardsIm cannabis corpAcquisition corpRa yarok pharm ltd